Welcome to Phoenix Rising!
Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.
To become a member, simply click the Register button at the top right.
Can't imagine who you mean Alvin :thumbdown:A certain politician uses this type of strategy and it works, lie and deflect over and over again and people will start believing it.
I've never seen so much swagger in a published commentary before.
PACE Critics That Look Like They’re About To Drop The Hottest PACE Critiques Ever:
Yet the claims in these publications also fall short in transparency and common sense. White, for example, wrote a Guardian commentary last fall after an independent group reanalyzed the recovery data and found null results (Matthees et al., 2016). In the commentary, White complained that the researchers had made “tweaks” to the outcome measures that made it harder for trial participants to achieve recovery thresholds (White, 2016). White failed to mention that those “tweaks” were simply the stricter recovery methods he and his colleagues had themselves promised in their protocol, and later abandoned. In other words, the reanalysis did not “tweak” anything—rather, it corrected the scientific record by un-tweaking the investigators’ own post hoc, unauthorized tweaks. These criteria changes had yielded 22 percent recovery rates for GET and CBT, rather than null results found in the reanalysis.
White also recently told The BMJ that it was unfair of critics to compare the high improvement rates from the Lancet paper with the lower improvement rates calculated from the protocol definition (Hawkes, 2016).“They’re comparing one measure with a completely different one — it’s apples and pears,” White said. Indeed it is. White and his colleagues took 5 million pounds in government funds and promised to bring back apples from the market. Instead they brought back pears, refusing to show anyone the apples they had rejected. Given the resources involved, it should not be hard to understand why people would want to examine those apples for themselves, to make their own comparisons with the pears and draw their own conclusions about whether their 5 million pounds were spent wisely. The investigators appear to view this public interest in accountability for public money as confusing or even offensive.
LOL. They all do these days.A certain politician uses this type of strategy and it works, lie and deflect over and over again and people will start believing it.
Not all.LOL. They all do these days.
He is rightly so concerned about the misuse of UK taxpayers fund, even as a US citizen.
Why are UK taxpayers and MP's not fuming given the parlous state of public finances and austerity??
In Australia, I would say almost all.Not all.
Too many though.
From the PACE cost analysis:Its a brand that they are growing and think they an throw a "CFS" MUS etc blanket over more and more patients.
From the PACE cost analysis:
"This study has found that CBT and GET are cost-effective options for treating patients with CFS. However, for patients to benefit from these therapies there needs to be investment to provide the staff trained to deliver them."
And this is exactly what's happening.........although they have now extended it to MUS and, thanks to SW et als drive to get the Govt to adopt the BPS model for all healthcare and supposedly 'remove the stigma of mental illness', it is all perfectly 'justified'.
eta: and it's spreading.
A trial that does not lead to any significant long term benefits for patients by definition is not cost effective, since the treatment doesn't work.
Oh, hang on a minute, of course it's cost effective because it:
a) gets heart sink patients out of their GP's hair
b) give an excuse not to pay disability benefits or insurance payouts.
Job done.
But their cost model doesn't include training costs or the lack of supply of therapists pushing costs up. If I remember their results were pretty marginal anyway.
Yea, I wonder why?They collected economic data with the long term follow up of PACE but have yet to publish.
The statistical distortion department is on vacationYea, I wonder why?
I wonder if that is because it undermines their assertions? Is there a link to anywhere where they discussed this at all?They collected economic data with the long term follow up of PACE but have yet to publish.
Economic data, such as sickness benefits and
employment status, have already been published by
McCrone et al.(2012). However, recovery from
illness is a health status, not an economic one, and
plenty of working people are unwell (Oortwijn
et al. 2011), while well people do not necessarily work.
Some of our participants were either past the age of
retirement or were not in paid employment when
they fell ill. In addition, follow-up at 6 months
after the end of therapy may be too short a period
to affect either benefits or employment. We therefore
disagree with Shepherd (2013) that such outcomes
constitute a useful component of recovery in the
PACE trial.
Indeed, the investigators appear perplexed that anyone would think of comparing the two sets of results. “It is no surprise,” they write, “that fewer participants are regarded as improved if more stringent criteria are applied.” By the same logic, it could have been “no surprise” to the PACE investigators themselves that more participants would be “regarded as improved”—and therefore reported as “improved” in their Lancet paper—if they substituted less stringent criteria to measure improvement rates in the trial.